Milestone Scientific Announces Successful Epidural Steroid Injection Procedures Under New AMA CPT Guidelines for Artificial Intelligence (AI) Assisted Pain Management Surgery

Milestone Scientific, a leading developer of computerized drug delivery instruments that provide painless and precise injections, as well as AI-assisted medical technology, announced the successful completion of the first series of epidural steroid injections (ESI) using the CompuFlo Epidural System by physicians under the new American Medical Association (AMA) Current Procedural Terminology (CPT) guidelines for AI-assisted analgesic epidural needle placement in patients.

AiThority Interview Insights: AiThority Interview with Darren Guarnaccia, President at Uniform

The AMA’s new technology-specific Category III CPT® code, which came into effect in the CPT codebook on January 1, 2023, specifically covers technologies that “integrate AI to place an epidural needle.” The published and copyrighted guidelines further note that the technology must include real-time software to assist the physician by transmitting key data points, along with sensors to interpret epidural pressures, detail anatomical needle placement, and measure precise saline volume via software facilitating data transmission to an epidural system console screen. The Company is not aware of any systems, other than the CompuFlo Epidural System, that would meet these criteria. Additionally, the technology is backed by a broad portfolio of domestic and international patents.

Arjan Haverhals, CEO and President of Milestone Scientific, stated, “We are proud to announce that multiple physicians have now completed ESI procedures using the CompuFlo Epidural System under the new AMA CPT guidelines for AI-assisted epidural needle placement. This is an important milestone, as it further validates the medical importance of the CompuFlo Epidural System by these physicians in their plans of treatment. Specifically, our proprietary and highly accurate AI-assisted technology enhances both the efficacy and safety of pain management surgery. We believe this data will play an important role as we seek reimbursement for the CompuFlo Epidural System under the new CPT® code.”

Read More about AiThority Interview: AiThority Interview with Brett Weigl, SVP and GM, Digital, AI and Journey Analytics at Genesys

Milestone Scientific Inc. (MLSS), a technology and artificial intelligence (AI)-focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase overall patient comfort and safety. The proprietary DPS Dynamic Pressure Sensing Technology^® is designed to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic.

 Latest AiThority Interview Insights : AiThority Interview with Mary-Lou Smulders, Chief Marketing Officer at Dedrone

 [To share your insights with us, please write to sghosh@martechseries.com]